Laura-Maria Krabbe

2.0k total citations
41 papers, 1.0k citations indexed

About

Laura-Maria Krabbe is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Laura-Maria Krabbe has authored 41 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Surgery, 22 papers in Pulmonary and Respiratory Medicine and 15 papers in Molecular Biology. Recurrent topics in Laura-Maria Krabbe's work include Bladder and Urothelial Cancer Treatments (26 papers), Renal cell carcinoma treatment (21 papers) and Urinary and Genital Oncology Studies (16 papers). Laura-Maria Krabbe is often cited by papers focused on Bladder and Urothelial Cancer Treatments (26 papers), Renal cell carcinoma treatment (21 papers) and Urinary and Genital Oncology Studies (16 papers). Laura-Maria Krabbe collaborates with scholars based in United States, Germany and Austria. Laura-Maria Krabbe's co-authors include Vitaly Margulis, Yair Lotan, Aditya Bagrodia, Arthur I. Sagalowsky, Shahrokh F. Shariat, Oussama M. Darwish, Solomon L. Woldu, Bishoy A. Gayed, Christopher G. Wood and Ahmed Haddad and has published in prestigious journals such as Cochrane Database of Systematic Reviews, The Journal of Urology and European Urology.

In The Last Decade

Laura-Maria Krabbe

40 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura-Maria Krabbe United States	20	615	531	310	185	122	41	1.0k
Denis Chautard France	15	442 0.7×	837 1.6×	472 1.5×	187 1.0×	99 0.8×	51	1.2k
Mark H. Kawachi United States	18	403 0.7×	552 1.0×	232 0.7×	145 0.8×	178 1.5×	37	1.1k
Giovanni Novella Italy	20	316 0.5×	742 1.4×	252 0.8×	129 0.7×	102 0.8×	64	981
Laurent Zini France	26	781 1.3×	1.1k 2.1×	783 2.5×	175 0.9×	197 1.6×	47	1.7k
Michael Froehner Germany	19	605 1.0×	761 1.4×	189 0.6×	222 1.2×	279 2.3×	80	1.3k
Joseph A. Pettus United States	19	853 1.4×	988 1.9×	537 1.7×	186 1.0×	340 2.8×	36	1.6k
Tsunenori Kondo Japan	20	699 1.1×	850 1.6×	411 1.3×	349 1.9×	114 0.9×	134	1.5k
Hugues Widmer Canada	27	1.2k 2.0×	880 1.7×	391 1.3×	260 1.4×	398 3.3×	48	1.8k
Daniel Pharand Canada	19	1.2k 1.9×	585 1.1×	219 0.7×	156 0.8×	163 1.3×	26	1.6k
Ariadne M. Bach United States	20	327 0.5×	520 1.0×	393 1.3×	230 1.2×	27 0.2×	34	1.1k

Countries citing papers authored by Laura-Maria Krabbe

Since Specialization

Citations

This map shows the geographic impact of Laura-Maria Krabbe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura-Maria Krabbe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura-Maria Krabbe more than expected).

Fields of papers citing papers by Laura-Maria Krabbe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura-Maria Krabbe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura-Maria Krabbe. The network helps show where Laura-Maria Krabbe may publish in the future.

Co-authorship network of co-authors of Laura-Maria Krabbe

This figure shows the co-authorship network connecting the top 25 collaborators of Laura-Maria Krabbe. A scholar is included among the top collaborators of Laura-Maria Krabbe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura-Maria Krabbe. Laura-Maria Krabbe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ivanyi, Philipp, Bernd Alt‐Epping, Lars Bullinger, et al.. (2025). Quality of Life of Cancer Patients in Routine Clinical Care Using the Example of Checkpoint Inhibition Therapy: A Delphi Consensus. Oncology Research and Treatment. 48(9). 498–505.

Krabbe, Laura-Maria, et al.. (2024). Immune-Related Adverse Events Can Predict Progression-Free and Overall Survival In Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors. Clinical Genitourinary Cancer. 22(5). 102164–102164. 1 indexed citations

Arranz, José Ángel, Omi Parikh, Laura-Maria Krabbe, et al.. (2024). Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis. Current Oncology Reports. 26(12). 1639–1650. 1 indexed citations

Krabbe, Laura-Maria, Georgios Gakis, & Yair Lotan. (2020). Clinical Utility of Bladder Cancer Biomarkers. 1(1). 62–67. 2 indexed citations

Zastrow, Stefan, Laura-Maria Krabbe, Ingmar Wolff, et al.. (2019). External validation of a postoperative nomogram for the prediction of disease-specific survival in patients with papillary renal cell carcinoma using a large multicenter database. International Journal of Clinical Oncology. 25(1). 145–150. 3 indexed citations

Rieken, Malte, Stephen A. Boorjian, Luis A. Kluth, et al.. (2018). Development and external validation of a pathological nodal staging score for patients with clear cell renal cell carcinoma. World Journal of Urology. 37(8). 1631–1637. 4 indexed citations

Krabbe, Laura-Maria, et al.. (2018). Therapeutic strategies for upper tract urothelial carcinoma. Expert Review of Anticancer Therapy. 18(8). 765–774. 21 indexed citations

Krabbe, Laura-Maria, Vitaly Margulis, Andres Jan Schrader, et al.. (2018). Molecularly-driven precision medicine for advanced bladder cancer. World Journal of Urology. 36(11). 1749–1757. 2 indexed citations

Woldu, Solomon L., Joseph A. Moore, Bo Ci, et al.. (2018). Practice Patterns and Impact of Postchemotherapy Retroperitoneal Lymph Node Dissection on Testicular Cancer Outcomes. European Urology Oncology. 1(3). 242–251. 12 indexed citations

10.

Woldu, Solomon L., Justin T. Matulay, Timothy N. Clinton, et al.. (2018). Incidence and Outcomes of Delayed Targeted Therapy After Cytoreductive Nephrectomy for Metastatic Renal-Cell Carcinoma: A Nationwide Cancer Registry Study. Clinical Genitourinary Cancer. 16(6). e1221–e1235. 15 indexed citations

11.

Woldu, Solomon L., Ahmet Murat Aydın, Ryan Hutchinson, et al.. (2017). Differences at Presentation and Treatment of Testicular Cancer in Hispanic Men: Institutional and National Hospital-based Analyses. Urology. 112. 103–111. 19 indexed citations

12.

Woldu, Solomon L., Bo Ci, Ryan Hutchinson, et al.. (2017). Usage and survival implications of surgical staging of inguinal lymph nodes in intermediate- to high-risk, clinical localized penile cancer: A propensity-score matched analysis. Urologic Oncology Seminars and Original Investigations. 36(4). 159.e7–159.e17. 23 indexed citations

13.

Krabbe, Laura-Maria, Aditya Bagrodia, Mary E. Westerman, et al.. (2015). Molecular profile of urothelial carcinoma of the upper urinary tract: are pelvicalyceal and ureteral tumors different?. World Journal of Urology. 34(1). 105–112. 6 indexed citations

14.

Youssef, Ramy F., Laura-Maria Krabbe, Shahrokh F. Shariat, et al.. (2015). TALL score for prediction of oncological outcomes after radical nephroureterectomy for high-grade upper tract urothelial carcinoma. World Journal of Urology. 33(12). 1965–1972. 10 indexed citations

15.

Singla, Nirmish, Bishoy A. Gayed, Aditya Bagrodia, et al.. (2015). Multi-institutional analysis of renal function outcomes following radical nephroureterectomy and partial ureterectomy for upper tract urothelial carcinoma. Urologic Oncology Seminars and Original Investigations. 33(6). 268.e1–268.e7. 28 indexed citations

16.

Lotan, Yair, Robert S. Svatek, Laura-Maria Krabbe, et al.. (2014). Prospective External Validation of a Bladder Cancer Detection Model. The Journal of Urology. 192(5). 1343–1348. 28 indexed citations

17.

Haddad, Ahmed, Christopher G. Wood, E. Jason Abel, et al.. (2014). Oncologic Outcomes Following Surgical Resection of Renal Cell Carcinoma with Inferior Vena Caval Thrombus Extending Above the Hepatic Veins: A Contemporary Multicenter Cohort. The Journal of Urology. 192(4). 1050–1056. 68 indexed citations

18.

Chung, Paul H., Laura-Maria Krabbe, Oussama M. Darwish, et al.. (2014). Degree of hydronephrosis predicts adverse pathological features and worse oncologic outcomes in patients with high-grade urothelial carcinoma of the upper urinary tract. Urologic Oncology Seminars and Original Investigations. 32(7). 981–988. 42 indexed citations

19.

Krabbe, Laura-Maria, Aditya Bagrodia, Vitaly Margulis, & Christopher Wood. (2014). Surgical Management of Renal Cell Carcinoma. Seminars in Interventional Radiology. 31(1). 27–32. 56 indexed citations

20.

Krabbe, Laura-Maria, Ahmed Haddad, Mary E. Westerman, & Vitaly Margulis. (2014). Surgical management of metastatic renal cell carcinoma in the era of targeted therapies. World Journal of Urology. 32(3). 615–622. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact